North Immunology and Aethlon Medical have agreed to merge in an all-stock deal, with North Immunology leading the combined company focused on developing NOR-101, a bispecific antibody targeting inflammation in atopic dermatitis. The merger includes an oversubscribed $180 million private placement to fund operations through mid-2028. NOR-101's Phase 1a trial is set to start in early 2027, with further clinical data expected in 2027 and 2028. The combined company will trade on Nasdaq under the ticker NRTX, aiming to advance NOR-101 as a potential best-in-disease treatment for immune and inflammatory diseases.
The merger of Aethlon Medical and North Immunology is the story's subject, here is Pluang's market snapshot for context. Of 91 priced Health-sector US stocks tradable on Pluang, 59 rose and 27 fell today. Notable movers include ASND at USD 239.50 with a 1-day change of -3.31% and Pluang order activity of 91% Sell / 9% Buy, SANA at USD 3.00 with a 1-day change of +2.74% and Pluang order activity of 86% Sell / 14% Buy, and AMWL at USD 13.60 with a 1-day change of +2.03%. This data is as of Sep 17, 2026 17:02 WIB.
Hansae Mobility inaugurated its Turan plant in Fergana, Uzbekistan, marking a strategic move to enhance local manufacturing and supply for global automakers. The facility will produce braking and steering components for over 310,000 vehicles annually...
Hansae Mobility inaugurated a new automotive parts factory in Fergana, Uzbekistan, expanding its global manufacturing network. The Turan plant will supply brake and steering components for over 310,000 vehicles annually, enhancing local production an...
Hansae Mobility inaugurated its new Turan factory in Fergana, Uzbekistan, expanding its global manufacturing footprint. This facility will produce brake components and steering parts for over 310,000 vehicles annually, enhancing supply responsiveness...
Zcash (ZEC) surged 11.56% over a four-hour period to reach $1,214 as of 1:10 p.m. ET on October 15, up from $1,088 four hours earlier. This increase also marked a 3.76% rise compared to its price 24 hours earlier, indicating a strong short-term gain....
Regions Financial is set to report its Q3 2026 earnings with expected EPS around $0.66 and revenue near $2 billion. The bank anticipates a 2% rise in net interest income and a 2.2% increase in fee income, but expects a 12.3% drop in capital markets r...
